Cost-utility analysis of normothermic and hypothermic ex-situ machine perfusion in liver transplantation
- PMID: 34904161
- PMCID: PMC10364715
- DOI: 10.1093/bjs/znab431
Cost-utility analysis of normothermic and hypothermic ex-situ machine perfusion in liver transplantation
Figures
Comment in
-
Comment on: Cost-utility analysis of normothermic and hypothermic ex-situ machine perfusion in liver transplantation.Br J Surg. 2022 Oct 14;109(11):e123. doi: 10.1093/bjs/znac258. Br J Surg. 2022. PMID: 35982618 No abstract available.
-
Author response to: Comment on: Cost-utility analysis of normothermic and hypothermic ex-situ machine perfusion in liver transplantation.Br J Surg. 2022 Oct 14;109(11):e124. doi: 10.1093/bjs/znac261. Br J Surg. 2022. PMID: 35982629 Free PMC article. No abstract available.
References
-
- Rayar M, Beaurepaire JM, Bajeux E, Hamonic S, Renard T, Locher C et al. Hypothermic oxygenated perfusion improves extended criteria donor liver graft function and reduces duration of hospitalization without extra cost: The PERPHO study. Liver Transpl 2021;27:349–362. - PubMed
-
- National Institute for Health and Care Excellence (NICE). The Reference Case | Guide to the Methods of Technology Appraisal 2013 | Guidance | NICE. 2020. https://www.nice.org.uk/process/pmg9/chapter/the-reference-case (accessed 16 August 2020). - PubMed
-
- Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366: l4898. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
